LIPID LOWERING TREATMENT PATTERNS AND RISK OF SUBSEQUENT CARDIOVASCULAR OUTCOMES AMONG PATIENTS WITH A RECENT CORONARY REVASCULARIZATION

We describe patient characteristics, lipid lowering therapy (LLT) use, and risks of subsequent cardiovascular events (CVE) in the 12-months following a coronary revascularization (CR). We identified patients undergoing CR between 01/2014-05/2019 (index period) in the linked IQVIA PharMetrics+/